These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7350323)

  • 41. A blinded, randomized, placebo-controlled trial to compare theophylline and doxapram for the treatment of apnea of prematurity.
    Peliowski A; Finer NN
    J Pediatr; 1990 Apr; 116(4):648-53. PubMed ID: 2181103
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A micromethod for the determination of serum theophylline.
    Melchior JB; Hommes PM; Jarrett TE; McClain W; Wasserlauf H
    J Am Osteopath Assoc; 1978 Jun; 77(10):777-9. PubMed ID: 659283
    [No Abstract]   [Full Text] [Related]  

  • 43. Effects of theophylline on the pattern of spontaneous breathing in preterm infants less than 1000 g of birth weight.
    von Poblotzki M; Rieger-Fackeldey E; Schulze A
    Early Hum Dev; 2003 May; 72(1):47-55. PubMed ID: 12706311
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Erythropoietin levels during theophylline treatment in premature infants.
    Gonzalez MT; Sherwood JB; Brion LP; Schulman M
    J Pediatr; 1994 Jan; 124(1):128-30. PubMed ID: 8283362
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Doxapram versus methylxanthine for apnea in preterm infants.
    Henderson-Smart DJ; Steer P
    Cochrane Database Syst Rev; 2000; (2):CD000075. PubMed ID: 10796115
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Randomized, controlled trial of oral creatine supplementation (not effective) for apnea of prematurity.
    Bohnhorst B; Geuting T; Peter CS; Dördelmann M; Wilken B; Poets CF
    Pediatrics; 2004 Apr; 113(4):e303-7. PubMed ID: 15060257
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Prevention of neonatal apnea with theophylline (author's transl)].
    Frisch H; Müller W; Irnberger E
    Monatsschr Kinderheilkd (1902); 1978 Nov; 126(11):684-6. PubMed ID: 723879
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Accuracy and reliability of dosing equations to individualize theophylline treatment of apnea of prematurity.
    Bhatt-Mehta V; Johnson CE; Donn SM; Spadoni V; Schork MA
    Pharmacotherapy; 1995; 15(2):246-50. PubMed ID: 7624272
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of theophylline on neurotransmitters in preterm infants with apnea.
    Bhat AM; Scanlon JW; Lavenstein B; Chuang L; Karoum F
    Clin Neuropharmacol; 1983 Mar; 6(1):71-4. PubMed ID: 6133614
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of caffeine in treatment of apnea in the low-birth-weight infant.
    Aranda JV; Gorman W; Bergsteinsson H; Gunn T
    J Pediatr; 1977 Mar; 90(3):467-72. PubMed ID: 14241
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Physiologic effects of doxapram in idiopathic apnea of prematurity.
    Barrington KJ; Finer NN; Peters KL; Barton J
    J Pediatr; 1986 Jan; 108(1):124-9. PubMed ID: 3080569
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacologic considerations in the therapy of neonatal apnea.
    Aranda JV; Grondin D; Sasyniuk BI
    Pediatr Clin North Am; 1981 Feb; 28(1):113-33. PubMed ID: 7208132
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetic aspects of theophylline in premature newborns.
    Aranda JV; Sitar DS; Parsons WD; Loughnan PM; Neims AH
    N Engl J Med; 1976 Aug; 295(8):413-6. PubMed ID: 934239
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predictive Factors for Efficacy and Safety of Prophylactic Theophylline for Extubation in Infants with Apnea of Prematurity.
    Kondo T; Kondo Y; Orita Y; Mitarai F; Ishitsuka Y; Irikura M; Shimodozono Y; Douchi T; Takeda Y; Irie T
    PLoS One; 2016; 11(7):e0157198. PubMed ID: 27388444
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cerebrospinal fluid concentration of biogenic amine metabolites in idiopathic apnea of prematurity.
    Bhat AM; Scanlon JW; Lavenstein B; Chuang L; Karoum F
    Biol Neonate; 1983; 43(1-2):16-22. PubMed ID: 6850011
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of three theophylline dosing equations for use in infants up to one year of age.
    Hogue SL; Phelps SJ
    J Pediatr; 1993 Oct; 123(4):651-6. PubMed ID: 8192745
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical pharmacology of theophylline in preterm infants: effects, metabolism and pharmacokinetics.
    Pacifici GM
    Curr Pediatr Rev; 2014; 10(4):297-303. PubMed ID: 25594527
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phenobarbital increases the theophylline requirement of premature infants being treated for apnea.
    Yazdani M; Kissling GE; Tran TH; Gottschalk SK; Schuth CR
    Am J Dis Child; 1987 Jan; 141(1):97-9. PubMed ID: 3788891
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Factors affecting the efficacy and safety of aminophylline in treatment of apnea of prematurity in neonatal intensive care unit.
    Ye C; Miao C; Yu L; Dong Z; Zhang J; Mao Y; Lu X; Lyu Q
    Pediatr Neonatol; 2019 Feb; 60(1):43-49. PubMed ID: 29673564
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical and physiological responses to prolonged nasogastric administration of doxapram for apnea of prematurity.
    Tay-Uyboco J; Kwiatkowski K; Cates DB; Seifert B; Hasan SU; Rigatto H
    Biol Neonate; 1991; 59(4):190-200. PubMed ID: 2070020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.